Pharma Industry News Archive

Pharma Industry News: September 2007

September 4 ViaCell Announces ViaCyte Collaboration with EMD Serono, Inc.
September 4 Positive Bioequivalence Study Results Trigger Milestone Payment for Eurand
September 4 InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
September 4 AstraZeneca Enhances Clinical Research Capabilities in China With First Clinical Pharmacology Unit
September 4 Pharmexa Loses European Patent Appeal for Broad Claims to Telomerase-Based Cancer Vaccines
September 4 Shire Voluntarily Withdraws a Limited Portion of Daytrana (Methylphenidate Transdermal System) Patches
September 4 Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
September 4 Noven Provides Update on Daytrana Methylphenidate Transdermal System
September 4 Canon Communications Acquires Engel Publishing Partners from Euromoney Institutional Investor PLC, Expanding Its Market Reach to Global Pharmaceutical Manufacturing Sector
September 5 Lundbeck and Takeda Form Alliance to Develop and Commercialize a Portfolio of Novel Compounds in the US and Japan for the Treatment of Mood and Anxiety Disorders
September 5 Ventana Medical Systems Acquires Spring BioScience
September 5 Bayer Intends to Delist from the New York Stock Exchange
September 5 Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
September 5 Public Communication - Health Canada Endorsed Important Safety Information on Ketek(telithromycin)
September 5 Colorcon Acquires Pharmaceutical Excipients and Coating Division of Chr. Hansen, Inc.
September 5 Forest Laboratories Announces Federal Appeals Court Upholds Lexapro Patent Decision
September 5 Teva Receives Favorable Court Decision Regarding Generic Famvir Tablets; Novartis' Motion for Preliminary Injunction Denied
September 6 AstraZeneca Launches and Prices a $6.9 Billion Bond Issue
September 6 FDA Approves First Generic Versions of Coreg
September 6 Pfizer Oncology Initiates Global Phase III Trial to Evaluate Sunitinib Malate Combined with Erlotinib in Advanced Non-Small Cell Lung Cancer
September 6 China Aoxing Pharmaceutical Company Receives Government Approval for Increased Ownership of its Main Operating Subsidiary, Hebei Aoxing; Amends Terms of the Acquisition Agreement
September 6 American Oriental Bioengineering Completes Acquisition of Changchun Xinan Pharmaceutical Group Company Ltd.
September 6 Biogen Idec Announces Strategic Updates at Investor Meetings
September 6 Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
September 6 Youth Drug Use at a Five Year Low, New Survey Shows
September 6 New Jersey High Court Denies Nationwide Class-Action Status to Insurance Companies Seeking Vioxx Reimbursements
September 6 CDC Report Shows Largest One-Year Increase in Youth Suicide Rate in 15 Years
September 7 Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
September 7 Theravance Retains Full Ownership of Gastrointestinal Motility Dysfunction Program and TD-1792 Antibiotic
September 7 Ablynx and Boehringer Ingelheim Announce Major Global Strategic Alliance to Discover, Develop and Commercialize Novel Nanobody Therapeutics
September 7 Sens. Grassley, Kohl Say Public Should Know When Pharmaceutical Makers Give Money to Doctors
September 7 Enzo Biochem, Inc. Files Appeal to Federal Court Decision
September 7 Publicis Groupe Announces Intention to Delist its American Depository Receipts (ADRs) from the New York Stock Exchange and to Deregister and Terminate its Reporting Obligations under the U.S. Securities Laws
September 7 Pozen/AstraZeneca Announce Start of the PN 400 Phase III Program
September 7 Isis and Alnylam Launch Regulus Therapeutics, a Joint Venture to Discover, Develop, and Commercialize microRNA Therapeutics
September 7 Novartis to Defend Its Intellectual Property Rights for Famvir Despite an "at-risk" Generic Launch in US
September 7 Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
September 7 This Week, Pharma Bloggers Criticize Merck’s Vioxx Studies, Pfizer’s Third Breach of Confidential Data, and the Bush Administration
September 10 Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
September 10 MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist
September 10 BioVascular, Inc. Merges with Revitus and Acquires First-In-Class Platelet Count Reducer
September 10 Repligen Announces Settlement with ImClone In Erbitux Lawsuit
September 10 United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
September 10 Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet
September 10 $52.5 Million Settlement Against Sepracor Inc. Approved
September 10 Pfizer Issues a Dear Healthcare Professional Letter to Inform Healthcare Professionals of the Presence of Ethyl Methanesulfonate in Viracept
September 10 Statement by Commissioner von Eschenbach on the Release of the Strategic Framework Document on Import Safety
September 11 Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
September 11 Evotec Sells its Chemical Development Business to Aptuit for GBP 31.5m (approx. EUR 46.4m; US$ 63.9m) in Cash
September 11 Alcon Waives Minimum Acceptance Condition for WaveLight AG
September 11 Biovail Says Settlement With Maris, BAS Expected to Be Helpful in Suit Against Hedge Funds and Others
September 11 Merck & Co., Inc. Announces Completion of NovaCardia, Inc. Acquisition
September 11 Aptuit to Acquire CPD Business of Evotec AG
September 11 Vote for the Most Admired Pharmaceutical, Biotechnology, and Specialty Companies
September 11 Adverse Drug Events Reported to FDA Appear to Have Increased Markedly
September 11 FDA - MedWatch - Rocephin (ceftriaxone sodium) - Dear Healthcare Provider Letter Clarifying Potential Risk Associated With Concomitant Use Of Rocephin With Calcium Containing Products
September 11 GlaxoSmithKline Responds to JAMA Articles
September 12 Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
September 12 FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent on October 10
September 12 Publicis Groupe Acquires Wcube, France’s Top Independent Digital Agency
September 12 Flamel Technologies Announces Medusa License Agreement with Wyeth Pharmaceuticals
September 12 Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
September 13 Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
September 13 Angiotech Receives Favourable Patent Decision from New Zealand's Intellectual Property Office
September 13 First Consulting Group (FCG) Announces Sale of FirstGateways Business to MedPlus, Inc.
September 13 FDA To Continue Its Review of Requests for Release of Clinical Hold on Alvimopan (Entereg)
September 13 FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol
September 13 New Licence for Cubicin (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
September 13 Canadian Court Finds Infringement of Lipitor Crystal Form Patent
September 13 IFRS Information - First Half of 2007
September 13 Physicians Urge Kennedy, Dodd to Support Curb on Financial Conflicts of Interest on FDA Advisory Committees
September 13 Cephalon Reinforces Important Prescribing and Dosing Information for Fentora
September 14 Novartis Completes Agreement with Bayer Schering Related to Betaseron Rights and Manufacturing
September 14 Sanofi-aventis Initiates Research Collaboration in China in the Cancer Stem-Cell Field
September 14 Bayer Completes Acquisition of U.S. Biologics Manufacturing Facility from Novartis
September 14 Bayer Completes Acquisition of U.S. Biologics Manufacturing Facility from Novartis
September 14 Four Leading Independent Proxy Advisory Firms Recommend Bausch & Lomb Shareholders Vote ''For'' Transaction with Warburg Pincus
September 17 Sanofi- aventis: A Promising R&D Portfolio, Well Positioned to Deliver Future Growth
September 17 FDA Approves Levaquin Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
September 17 Depomed Announces Reduction in Force
September 17 AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications
September 17 AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications
September 17 United BioSource Acquires Caro Research, Leader in Simulation Modeling
September 17 LabPas CT Selected by Qualia Clinical Services for Phase I Clinical Trials
September 18 FDA Clears Genetic Lab Test for Warfarin Sensitivity
September 18 FDA Alerts Healthcare Professionals to Deaths Linked to Haloperidol
September 18 FDA - MedWatch - Haloperidol Marketed As Haldol, Haldol Decanoate, And Haldol Lactate Get New Warnings And Revised Prescription Information
September 18 Pharmaceutical Marketers to Spend $2.2 Billion Online in 2011
September 18 LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
September 18 GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
September 18 Roche Announces Tamiflu Will be in Ample Supply for 2007-2008 Flu Season
September 18 Merck & Co., Inc. Response to Today's New York Medicaid Suit
September 18 N.Y. AG Cuomo, Mayor Bloomberg Sue Maker of Vioxx for Hiding Drug’s Risks
September 19 Bavarian Nordic Strengthens its Commercial Organisation and Updates on Pipeline Progress
September 19 Esprit Pharma, Inc. to Be Aquired by Allergan, Inc.
September 19 NJAG Milgram Announces Task Force to Study the Influence of Gift-Giving to Physicians by Pharmaceutical Manufacturers, Medical Device Makers
September 19 Orexigen Announces Settlement Agreement with Eisai
September 19 Alnylam Announces the Termination of its Collaboration with Merck & Co., Inc.
September 19 Baby Boomers Want Control of Their Own Health and Actively Seek out Information from Multiple Sources to Help Make Decisions
September 20 Ventana Responds to Third Extension of Roche's Unsolicited Tender Offer
September 20 Sanofi pasteur First Manufacturer to Ship Doses of Influenza Vaccine for the 2007-2008 Season
September 20 Roche Extends Tender Offer for Ventana
September 20 Karo Bio Development of Clinical Candidate LXR-623 Discontinued
September 20 PSI Brings its Pioneering Efforts to a Close
September 20 New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
September 21 European License for Roche HIV Drug Viracept Recommended for Reinstatement
September 21 FDA Sends Kunshan Chemical & Pharmaceutical Company Letter About its Facilities
September 21 Statement by FDA Commissioner Andrew C. von Eschenbach on Passage of FDA Amendments Act of 2007 (FDAAA)
September 21 Exelixis Research Collaboration With Bristol-Myers Squibb Extended
September 21 Bausch & Lomb Shareholders Approve Merger with Affiliates of Warburg Pincus
September 21 Court Rules for Pfizer in Patent Infringement Case on Neurontin
September 21 Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate
September 21 Biomax Informatics AG Acquires Data Mining Business from eudaptics software gmbh
September 24 Teva Provides Update On Generic Neurontin Litigation
September 24 Biogen Idec Announces Research Collaboration with Johns Hopkins Brain Science Institute
September 24 Bristol-Myers Squibb to Acquire Adnexus Therapeutics
September 24 Elixir Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
September 24 US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer
September 24 Dyadic Announces Termination of Employment of its President and CEO, Mark A. Emalfarb
September 24 Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
September 24 MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
September 24 New Brunswick Scientific Completes Merger Transaction with Eppendorf
September 25 Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
September 25 GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
September 25 Aranesp DAHANCA 10 Study Results Presented at ECCO Annual Meeting
September 25 TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimer's Disease
September 25 Panacos Announces Management Changes
September 25 Impact of discontinuation of Merck HIV study on Crucell's prospects
September 25 Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
September 25 Barr Confirms Patent Challenge of Uroxatral
September 26 Palatin Technologies Announces Reduction of Workforce
September 26 Depression Intervention in Workplace Increases Employee Productivity 2.6 Hours a Week
September 26 Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
September 26 Verispan's Vector One: Antidepressant Prescribing Decreases in Teenagers
September 26 Exclusive Agreement Announced Between Quidel Corporation and Roche Pharma AG
September 26 FDA Warns of Potential Serious Side Effects with Breakthrough Cancer Pain Drug
September 27 FDA, Leading Pharma Companies Launch Global Collaboration to Research Genetic Markers Linked to Drug Safety
September 27 PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
September 27 Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp
September 27 Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
September 27 Taisho and BrainCells Signed a License Agreement for Taisho's New Drug Candidates of CNS Indications
September 27 PhRMA Statement on Enactment of FDA Legislation
September 27 Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
September 28 Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
September 28 Celera Announces Clinical Milestone Payment from Merck
September 28 Novartis and Massachusetts Institute of Technology in New Partnership Aimed at Transforming Pharmaceutical Manufacturing
September 28 Eisai Announces Establishment of New Pharmaceutical Marketing Subsidiary in Belgium
September 28 Alcon Gains 76.9 Percent of WaveLight Shares and Will Move Forward with Acquisition
September 28 Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
September 28 OIG Releases Report of FDA’s Oversight of Clinical Trials, Concludes Improvement of Information Systems and Processes is Needed
September 28 Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
September 28 Canadian Federal Court Upholds Viagra Patent
September 28 FDA Takes Action to Stop Marketing of Unapproved Hydrocodone Products
September 28 Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
September 28 FDA-MedWatch -Gadolinum Based Contrast Agents: Dear Healthcare Professional Letter Issued Regarding Boxed Warning And Revisions to Warning Section of Prescribing Information

Pharma Industry News Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

MedNotes
Advertisement

(web3)